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1 Introduction
Peri-intraventricular hemorrhage (PIVH) is the
most common type of neonatal intracranial hem-
orrhage in preterm infants and may account for
much of the subsequent morbidity in neonatal
survivors with hydrocephalus, cerebral palsy or
mental retardation [10]. The true timing of PIVH
is a crucial information to an understanding of
etiologic factors and their possible prevention [7,
12]. Transfontanelle real-time ultrasonography
(US) has been used as method of choice to detect
and follow PIVH [14]. With the availability of
repetitive examinations it has been possible to
study the optimal timing for the ultrasono-
graphic diagnosis of hemorrhagic lesions in pre-
terms. However, its maximal diagnostic effi-
ciency lies between day 4 and 14 since fresh blood
may initially appear sonolucent [19].
Increased levels of brain type Creatine Kinase
Isoenzyme (CPK-BB) reflect cellular injury and
have been found in serum of preterm neonates
with PIVH [1, 4, 18]. Because of the supposed
interval required for clot formation to become
visible on ultrasound, we used serial measure-
ments of serum brain-typical CPK performed in
the first 60 hours of life to determine the bio-
chemical timing of PIVH. The purpose of our
study was to investigate in a group of 50 preterm
infants less than 1500 g birth weight the useful-
ness of serum CPK-BB determination in the de-
tection of PIVH and to compare the neuroson-
ographic and biochemical timing of such cerebral
lesions.
2 Patients and methods
From August 1987 to October 1988 fifty appro-
priate for gestational age infants weighing be-
tween 780 and 1480 g at birth (26-34 weeks
gestation) and admitted to the Neonatal Inten-
sive Care Unit (NICU) of our Neonatal Division
were studied. Sequentially admitted infants were
enrolled prospectively in this study after in-
formed parental consent was obtained. All pa-
tients were inborn and those with congenital
anomalies or product of multiple gestation were
excluded. The gestational age was determined by
maternal history, prenatal ultrasonographic as-
sessment as well as physical and neurological
assessment using the criteria of BALLARD et al
[3] and by examination of the anterior capsule
of the lens [2]. The patients received standard
care by the attending neonatologist and therapy
regimens were not altered for the purpose of this
study. Details of the gestation, labor, delivery
and data collected in the perinatal period includ-
ing medications and all significant events such
as seizures, pneumothoraces and need of assisted
ventilation were recorded. Admitting diagnoses
were most commonly respiratory distress syn-
drome (RDS) (78%) and presumed neonatal in-
fection (20%). Other selected perinatal risk fac-
tors for PIVH are displayed on table I.
2.1 Neurosonography
Ultrasound examination of the newborn brain
was performed as soon as possible after admis-
sion to the NICU. Further examinations were
performed at 24 hours of life, every day in the
first week and weekly thereafter until discharge.
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Table I. Selected perinatal risk factors for PIVH
Mode of delivery
Cesarean/vaginal
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n. s.* = not statistically significant
An ATL ultramark 4 (Advanced Technology
Laboratories) sector Scanner with 5 and 7.5
MHz transducers was used. The scans were per-
formed through the anterior fontanel in coronal
and sagittal planes and reviewed by observers
unaware of the infant's clinical course and other
study findings. For classification of PIVH, Pap-
ile's grading system was used [15]: Grade I, su-
bependymal hemorrhage; Grade 2, intraventri-
cular hemorrhage; Grade 3, intraventricular
hemorrhage with ventricular dilation; Grade 4,
intraventricular hemorrhage with parenchymal
involvement. The time of ultrasonographic oc-
currence of PIVH was calculated using the day
at wich the abnormality was first detected.
increase of NADH was measured fluorometri-
cally. Direct scanning of isoenzyme kinetics zone
electrophoresis allows exact quantification of
isoenzyme patterns.
2.3 Statistics
As described above, infants were grouped for
purposes of data analysis according to the pres-
ence of PIVH as detected by neurosonography.
The data were analysed by Chi-Square Test and
unpaired Student's t-test where appropriate. P
values < 0.05 were considered significant.
2.2 Enzyme analysis
CPK-BB was measured in all patients immedi-
ately after delivery in capillary blood (TO) then
serially at 6-10 hours (Tl), 20-30 h (T2) and
40-60 h (T3) of life. Heel-prick capillary blood
specimens were collected in Microtainer tubes.
The volume of whole blood obtained ranged
from 0.3 to 0.5 ml. It was centrifugated within
30 minute after collection, serum being separated
and stored at —20 °C. The technologist perform-
ing the analysis was not aware of the subiect's
condition. For determination of total CPK-BB
serum activity a new and very sensitive method
was used as described by BUCHER et al [6]. One
to three microliters of serum were electro-
phoresed on cellulose acetate strips for 20 min
at 300 V. Using a Sigma Scanner FTR-20 con-
nected to a Spectraphysic Integrator SP 4100 the
3 Results
The birth weight of the 50 infants was 1120
± 320 g and their gestational age 30 + 3.7 weeks
(table II). The overall incidence of PIVH was
30% (15 cases). Most commonly hemorrhage
was detected in the subependymal area (8 pa-
tients, 16%). PIVH Grade 2 was observer in six
infants (12%). Only one patient (2%) had PIVH
Grade 3 with ventricular dilation. No cerebral
parenchymal involvement was observed. None
of the infants died during the study period. The
infants were evaluated for the presence or ab-
sence of a number of risk factors according to
PIVH grouping. The infants with no PIVH were
found to have significantly higher gestational age
(p < 0.05) and significantly higher Apgar Scores
at one minute of life (p < 0.05). There were no
significant differences in birth weights, Apgar
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n. s.* = not statistically significant
Scores at five minutes of life, cesarean section,
need and duration of assisted ventilation, pneu-
mothoraces and apneic spells among the two
groups of babies. Sex distribution reflected all
nursery admissions (23 boys, 27 girls). The age
of onset of PIVH was less than 24 hours in two
infants (13%), 24 to 48 hours in three (20%), 48
to 72 hours in nine (60%) and 72 to 96 hours in
one patient (6%). No PIVH developed after this
time and no extension of the original bleeding
was observed in any case. Ultrasound evidence
of resolution of the hemorrhage occurred as early
as ten days and as late as three months after
PIVH was first diagnosed. Ventricular dilation
first diagnosed in the patient with Grade 3 PIVH
on day 12 of life was moderate without progres-
sion of the initial degree and resolved within two
months after occurrence. To determine the op-
timal timing for diagnostic ultrasound we looked
at the percentage of PIVH detected at each scan-
ning interval among the number of patients with
PIVH. Maximal diagnostic efficiency for PIVH
was on day three of life (60% of the studied
infants with PIVH were detected on US on this
time). The subjects with PIVH had an average
CPK-BB level at to more than three times that
of patients without PIVH. At delivery, the 15
patients with proven PIVH on ultrasound had
mean CPK-BB values of 70.8 ± 30.5 U/l com-
pared to 20.9 ± 10.7 U/l in the group without
PIVH (p < 0.05) (table II). No significant differ-
ence was present on similar analyses performed
at 6 -10 h (Tl), 20 - 30 h (T2) and 40 - 60 h (T3)
of life. In 73% (11 cases) of the analyses per-
formed on these three last times (Tl, T2, T3),
CPK-BB isoenzyme was not present. In only four
cases (26%) serum CPK-BB levels were very low
at Tl but the difference betweeen the two groups
of patients was not statistically significant (mean
values 10.7 ± 2.9 vs 9.6 ± 3.4 U/l) (p > 0.05).
Only subjects with CPK-BB values greater than
30 U/l at birth were at high risk to develop PIVH
detected then by neurosonography on the third
day of life. In this study we did not search for a
correlation between CPK-BB level and degree of
PIVH.
4 Discussion
In view of current interest to establish the pre-
dictive value of perinatal risk factors associated
with PIVH, it is of interest to note that previous
studies using real-time ultrasound scanning re-
port maximal efficiency for diagnosis of PIVH
on day 14 [16, 20]. Significant intraventricular
hemorrhage may be missed by ultrasound, par-
ticularly if ultrasound scan is obtained within
few days of the time of hemorrhage since fresh
blood may initially appear sonolucent [5]. As a
fibrin clot organizes, it becomes visible as a
bright echo. Because of the interval required for
clot formation, serial ultrasound examinations
of the infant for up to four days of age may be
required to detect the presence of hemorrhage.
TSIANTOS et al [21] routinely labeled erythrocytes
of neonates with Chromium 51 within the first
few hours of life and found that 60% of the
hemorrhages took place between 15 and 48 hours
of age. FUJIMURA et al [9] using hemoglobin as
a marker, observed that infants less than 28
week's gestation were more likely to sustain
PIVH in the first 24 hours of life than infants of
greater gestational age. The authors concluded
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that these early hemorrhages are common in very
low birth weight infants and that they are prob-
ably related to adverse parinatal factors. Al-
though we did not observe in our collective such
division of timing in relation to gestational age,
we speculated that perinatal factors are the prev-
alent cause of PIVH and that they are more
important than neonatal factors with regard to
the etiology of PIVH [13]. However, performing
the first ultrasound examination as soon as pos-
sible after delivery (within the first six hours of
life) in only two cases we were able to demon-
strate an hemorrhage at this time. In the other
13 studied cases we were not able to diagnose
PIVH before the third day of life. Our hypothesis
on earlier timing of PIVH in preterm infants was
proved using serial CPK-BB evaluations. Several
studies have shown that measurements of CPK-
BB activity is useful for prognosis in neonate at
risk of brain damage [8, 22]. In adults this brain
specific enzyme is significantly present in serum
of patients following cerebrovascular injury. In
our study, preterm infants with PIVH have also
significant elevations in serum levels of CPK-BB
at birth. Although it is known that CPK-BB is
present in small amounts in the lung, intestine,
kidney and placenta, it is demonstrated that any
disorder that injuries CNS cells results in a con-
siderable elevation of enzymatic levels that can
be detected in the cerebrospinal fluid and in
serum [5]. In preterm infants PIVH accounts for
the majority of CNS destructive disease. There-
fore in these patients elevated CPK-BB values
should be considered relatively specific for hem-
orrhagic lesions and CNS the likely source of
CPK-BB elevations. HAMBLETON and WIGGLES-
WORTH [10] have clearly shown that PIVH orig-
inates in the subependymal layer as a result of
capillary rupture or venous stasis secondary to
hypercapnia and hypoxia. The hypothesis that
in our patients the CNS injury occurs in the early
perinatal period is confirmed by the results ob-
tained at time of birth. The regularity of high
CPK-BB values at TO suggests that a process is
set in motion near the time of birth and culmi-
nates in PIVH. Moreover, in our study, infants
with PIVH had a significantly lower Apgar Score
at one minute of life compared to those without
PIVH. Perinatal hypoxia and ischemia are fac-
tors that may predispose the premature infant
to PIVH [23] as confirmed by elevated CPK-BB
values observed in our patients immediately after
delivery. We were unable to identify a second
peak on the second or third day of life as de-
scribed by SHIELDS et al [18]. Early perinatal cell
destruction results in release of CPK-BB but
serum enzymatic levels decreased in our collec-
tive rapidly from 4 to 10 hours of life. In ac-
cordance with some experimental studies [4, 5]
it is known that CPK-BB half-life is very short.
This fact suggests that the assay should be per-
formed soon after birth or soon after any as-
phyctic event to be of prognostic value. Our
findings have useful practical implications re-
garding the management of very low birth weight
infants. To program clinical trials for prevention
of PIVH it is of major importance to delineate
the real timing of occurrence of such lesions in
a population at risk [11,17]. In this way a better
understanding of the true etiologic factors of this
condition may emerge, thus allowing identifica-
tion of preventable ones.
Abstract
Precise diagnosis of peri-intraventricular hemorrhage
(PIVH) requires brain real-time ultrasound imaging
procedure (US). However, maximal diagnostic effi-
ciency of US lies between day 4 and 14 since fresh
blood may initially appear sonolucent. Because of this
supposed interval required for clot formation to be-
come visible on US, serum CPK-BB estimations were
performed in the first 60 hours of life to determine
precise biochemical timing of PIVH. A group of 50
preterm infants less than 1500g birth weight (1120
± 320 g) and 34 weeks gestation (30 ± 3.7 weeks) was
studied. Serial CPK-BB measurements were performed
in serum immediately after birth (TO), then serially at
time Tl (6-10 h), T2 (20-30 h), T3 (40-60 h). The
incidence of PIVH diagnosed on the third day of life
was 30%. Total CPK-BB values at TO in infants who
developed PIVH were significantly higher than those
of patients without cerebral bleeding (70.8 + 30.5 vs
20.9 ± 10.7 U/l) (p < 0.05). The same statistically sig-
nificant results were not observed analysing the CPK-
BB values at Tl, T2 and T3.
These results suggest that most pathological conditions
responsible for enzyme release occur in the pre- or
perinatal period.
Keywords: Brain specific Creatine Kinase isoenzyme, peri-intraventricular hemorrhage, preterm infants.
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Zusammenfassung
Biochemische Erfassung von peri-intraventrikulären Blu-
tungen durch postnatale CFK-Bestimmungen
Die präzise Diagnose der peri-intraventrikulären Blu-
tung (PIVH) wird heute mit der cerebralen Ultraschall-
untersuchung erreicht. Jedoch zeigt auch die Ultra-
schalluntersuchung ihre maximale diagnostische Spe-
zifität erst zwischen dem 4. und 14. Tag, dies weil
frisches Blut initial echoann ist. Um in diesem Inter-
vall, indem es durch die Thrombinausbildung zu einer
zunehmenden Echodensität im Ultraschall kommt,
eine PIVH diagnostizieren zu können, wurden CPK-
BB Bestimmungen im Serum durchgeführt. Eine
Gruppe von 50 Frühgeborenen mit einem mittleren
Geburtsgewicht unter 1500 g (1120 + 320) und einem
mittleren Gestationsalter unter 34 (30 ± 3,7) Wochen
wurde studiert. Die serienmäßigen CPK-BB Bestim-
mungen wurden unmittelbar nach der Geburt (TO) ein
zweites Mal mit 6-10 Stunden (Tl), ein drittes Mal
mit 20-30 Stunden (T2) und ein viertes Mal mit 40-
60 Lebensstunden (T3) durchgeführt.
Die Inzidenz der nach dem 3. Tag sonographisch dia-
gnostizierten PIVH betrug 30%.
Die CPK-BB Werte zum Zeitpunkt TO waren in der
Gruppe, der sonographisch festgestellten PIVH signi-
fikant höher als bei der Gruppe ohne PIVH (70,8
± 30,5) versus (20,9 ± 10,7) mit p < 0,05. Es fanden
sich keine signifikanten Unterschiede, wenn die CPK-
BB Werte zum Zeitpunkt Tl, T2 und T3 miteinander
verglichen wurden.
Diese Resultate zeigen, daß die meisten pathologischen
Prozesse, die zu einer Enzymfreisetzung fuhren, ihren
Ursprung in der prae- oder perinatalen Periode haben.
Schlüsselwörter: Frühgeborene, hirnspezifisches Kreatinkinase-Isoenzym, peri-intraventrikuläre Blutung.
Resume
Le timing biochinique des hemorrage peri-intraventri-
culaires mesure avec l'enzyme CPK-BB
La diagnostic precis de Fhemorragie peri- intraventri-
culaire se fait aujourd'huipar la sonographie cerebrale.
Pourtant efficacite diagnostique maximale de la so-
nographie cerebrale se situe seulement entre le 4ieme
et le 14ieme jours en raison de Pechogenicite faible du
sang frais. Considerant cet Intervalle necessaire pour
rendre visible la formation thrombotique a la sono-
graphie, nous avons ajouteune mesure de la CPK-BB
afin de determiner le temps d'apparition de la PIVH.
Un groupe de 50 enfants preematures d'un poids in-
ferieur ä 1500 g (1120 ± 320) et avec un age gestationel
moyen de 30 ± 3,7 semaines a ete examine.
La mesure en serie de la CPK-BB etait effectuee pour
une premiere fois peu apres la naissance (TO), une
deuxieme fois apres 6 ä 10 heures (Tl), une troisieme
fois apres 20 ä 30 heures (T2) et une derniere fois a
l'äge de 40 a 60 heures (T3).
La diagnostic sonographique de la PIVH ce faisait
chez 30% des enfants apres la troisieme jours de vie.
La valeur de la CPK-BB au TO a montre une elevation
significative chez les enfants avec PIVH, les valeurs
moyenne etant 70,8 ± 30,5 pour les enfants avec PIVH
et 20,9 ± 10,7 pour les enfants sans PIVH.
Nous avons pas trouve une difference significative dans
les valeurs prises au Tl, T2 et T3.
Ces resultats indiquent que les conditons patholo-
giques creant une augmentation d'enzyme libre ont
lieu durant la periode prae- ou perinatale.
Mots-cles: Enfants prematures, hemorragie peri-intraventriculaire, isoenzyme cerebral de la creatine kinase.
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